Colorimetric Evaluation of the Time-Killing Assay for Citropin 1.1, Lipopeptide Palm-KK-, and Temporin A |
Baranska-Rybak, Wioletta
(Department of Dermatology, Venerology and Allergology, Faculty of Medicine, Medical University of Gdansk)
Dawgul, Malgorzata (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk) Bielinska, Sylwia (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk) Kraska, Bartlomiej (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk) Piechowicz, Lidia (Department of Microbiology, Faculty of Medicine, Medical University of Gdansk) Kamysz, Wojciech (Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gdansk) |
1 | Boland, M. P. and F. Separovic. 2006. Membrane interactions of antimicrobial peptides from Australian tree frogs. Biochim. Biophys. Acta 1758: 1178-1183. DOI ScienceOn |
2 | Bulet, P., R. Stöcklin, and L. Menin. 2004. Anti-microbial peptides: From invertebrates to vertebrates. Immunol. Rev. 198: 169-184. DOI ScienceOn |
3 | De Smet, K. and R. Contreras. 2005. Human antimicrobial peptides: Defensins, cathelicidins and histatins. Biotechnol. Lett. 27: 1337-1347. DOI ScienceOn |
4 | Fields, G. B. and R. L. Noble. 1990. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acides. Int. J. Pept. Protein Res. 35: 161-214. |
5 | French, G. L. 2006. Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin. J. Antimicrob. Chemother. 58: 1107-1117. DOI ScienceOn |
6 | Gee, T., R. Ellis, G. Marshall, J. Andrews, J. Ashby, and R. Wise. 2001. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob. Agents Chemother. 45: 1843-1846. DOI ScienceOn |
7 | Ghiselli, R., A. Giacometti, O. Cirioni, F. Mocchegiani, C. Viticchi, G. Scalise, and V. Saba. 2002. Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. J. Surg. Res. 108: 107-111. DOI ScienceOn |
8 | Giacometti, A., O. Cirioni, W. Kamysz, C. Silverstri, A. Licci, A. Riva, J. Lukasiak, and G. Scalise. 2005. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides 26: 2111-2116. DOI ScienceOn |
9 | Guaní-Guerra, E., T. Santos-Mendoza, S. O. Lugo-Reyes, and L. M. Terán. 2010. Antimicrobial peptides: General overview and clinical implications in human health and disease. Clin. Immunol. 135: 1-11. DOI ScienceOn |
10 | Guerin, T. F., M. Mondido, B. McClenn, and B. Peasley. 2001. Application of resazurin for estimating abundance of conrtaminantdegrading microorganism. Lett. Appl. Microbiol. 32: 340-345. DOI ScienceOn |
11 | Hanberger, H., L. E. Nilsson, R. Maller, and B. Isaksson. 1991. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of and albumin on these drugs. Antimicrob. Agents Chemother. 35: 1710-1716. DOI ScienceOn |
12 | Kamysz, W. 2005. Are antimicrobial peptides an alternative for conventional antibiotics? Nucl. Med. Rev. 8: 78-86. |
13 | Hancock, R. E. W. and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43: 1317-1323. |
14 | Hancock, R. E. W. 1997. Peptides antibiotics. Lancet 349: 418-422. DOI ScienceOn |
15 | Hyatt, J. M., D. E. Nix, and J. J. Schentag. 1994. Pharmacokinetic and pharmacodynamic activites of ciprofloxacin against strains of Streptococcus pneumonia, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar. Antimicrob. Agents Chemother. 38: 2730-2737. DOI ScienceOn |
16 | Kamysz, W., C. Silverstri, O. Cirioni, A. Giacometti, A. Licci, A. Della Vittoria, M. Okroj, and G. Scalise. 2007. In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH2 and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant Gram-positive cocci. Antimicrob. Agents Chemother. 51: 354-358. DOI ScienceOn |
17 | Kuper, K. M., D. M. Boles, J. F. Mohr, and A. Wanger. 2009. Antimicrobial suspectibility testing: A primer for clinicians. Pharmacotherapy 29: 1326-1343. DOI ScienceOn |
18 | Levison, M. E. 2000. Pharmacodynamics of antibacterial drugs. Infect. Dis. Clin. North Am. 14: 281-291. DOI ScienceOn |
19 | Levison, M. E. and J. H. Levison. 2009. Pharmacokinetics and pharmacodynamics of antibacterial drugs. Infect. Dis. Clin. North Am. 23: 791-815. DOI ScienceOn |
20 | Stevens, D. L., B. Dotter, and K. Madaras-Kelly. 2004. A review of linezolid: The first oxazolidinone antibiotic. Expert Rev. Anti Infect. Ther. 2: 51-59. DOI ScienceOn |
21 | Stewart, J. M and J. D. Young. 1984. Solid Phase Peptide Synthesi, 2nd Ed. Pierce Chemical Company, Rockford, IL USA. |
22 | Barlos, K., O. Chatzi, D. Gatos, and G. Stavropoulos. 1991. 2- Chlorotrityl chloride resin. Studies on anchoring of Fmoc-amino acids and peptide cleavage. Int. J. Pept. Protein Res. 37: 513-520. |